<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Mol Biol</journal-id><journal-title>BMC Molecular Biology</journal-title><issn pub-type="epub">1471-2199</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2199-10-68</article-id><article-id pub-id-type="pmid">19575803</article-id><article-id pub-id-type="doi">10.1186/1471-2199-10-68</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Expression of HNF4alpha in the human and rat choroid plexus &#x02013; Implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Niehof</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>niehof@item.fraunhofer.de</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Borlak</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>juergen.borlak@item.fraunhofer.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Fraunhofer Institute for Toxicology and Experimental Medicine, Center of Molecular Medicine and Medical Biotechnology, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany</aff><aff id="I2"><label>2</label>Center of Pharmacology and Toxicology, Medical School of Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>3</day><month>7</month><year>2009</year></pub-date><volume>10</volume><fpage>68</fpage><lpage>68</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2199/10/68"/><history><date date-type="received"><day>1</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>3</day><month>7</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Niehof and Borlak; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Niehof and Borlak; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Niehof Monika niehof@item.fraunhofer.de </dc:author><dc:title> Expression of HNF4alpha in the human and rat choroid plexus &#x02013; Implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>BMC Molecular Biology 10(1): 68-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2199(2009)10:1&#x0003c;68&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2199</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The choroid plexus consists of highly differentiated epithelium and functions as a barrier at the interface of the blood-cerebrospinal-fluid (CSF). This tissue may therefore determine the bioavailability and transport of drugs to the brain. Little is known about the expression of drug and xenobiotic metabolizing enzymes (DME) and of drug transporters in the human choroid plexus. Notably, the transcription factor and zinc finger protein HNF4alpha is a master regulator of DMEs and of drug transporters. As of today its activity in the blood-CSF barrier is unknown. Here we report our efforts in determining HNF4alpha activity in the regulation of ABC transporters in the human and rat choroid plexus.</p></sec><sec><title>Results</title><p>We report expression of HNF4alpha by qRT-PCR and by immunohistochemistry and evidence transcript expression of the ATP-binding cassette transporters ABCB1, ABCB4, ABCC1-6 in choroid plexus. Additionally, HNF4alpha DNA binding activity at regulatory sequences of ABCB4 and ABCC1 was determined by EMSA bandshift assays with a specific antibody. We then performed siRNA mediated functional knock down of HNF4alpha in Caco-2 cells and found ABCC1 gene expression to be repressed in cell culture experiments.</p></sec><sec><title>Conclusion</title><p>Our study evidences activity of HNF4alpha in human and rat choroid plexus. This transcription factor targets DMEs and drug transporters and may well determine availability of drugs at the blood-CSF barrier.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Drug delivery to the brain is mediated by several factors, most notably transport across the blood brain (BB) and the choroid plexus barrier; the latter displays drug-metabolizing enzyme and drug transport activity. It may therefore determine the overall cerebral bioavailability of drugs [<xref ref-type="bibr" rid="B1">1</xref>]. Specifically, the choroid plexus is located within brain vesicles. It is composed of a tight monolayer of polarized epithelial cells and forms the blood-cerebrospinal-fluid (CSF) barrier. Together with the blood-brain barrier, formed by endothelial cells of brain capillaries, it functions as the main interface between the central nervous system (CNS) and the peripheral circulation. Within the CNS this tissue is of great pharmacological interest, but information on the expression of efflux transporters such as the ATP binding cassette (ABC) proteins is missing [<xref ref-type="bibr" rid="B2">2</xref>]. In contrast, their expression in liver, kidney, and intestine has been studied in considerable detail [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. Indeed, the ABC drug transporters extrude a variety of structurally diverse drugs, drug conjugates and metabolites in an active, ATP-dependent manner and even against high concentration gradients. The three main ABC families considered to be involved in the disposition of xenobiotics include the ABCB family (MDR subfamily, multidrug resistance, e.g. ABCB1/MDR1), the ABCC family of multidrug resistance proteins (MRP subfamily, multidrug resistance related proteins, e.g. ABCC2/MRP2), and the breast cancer resistance protein (ABCG2/BCRP) of the ABCG family [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. However, comprehensive studies on the expression levels of ATP transporters in the human choroid plexus have not been attempted.</p><p>Notably, there is clear evidence for HNF4&#x003b1; to play a role in the transcriptional control of drug transporters. Specifically, HNF4&#x003b1; is a member of the nuclear receptor superfamily and one of the key players in liver biology [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. Among the genes regulated by HNF4&#x003b1; are a broad range of xenobiotic-metabolizing cytochrome P450 isozymes [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>], UDP-glucuronosyltransferases [<xref ref-type="bibr" rid="B11">11</xref>], sulfotransferases [<xref ref-type="bibr" rid="B12">12</xref>] and transporters including organic anion transporter 2 [<xref ref-type="bibr" rid="B13">13</xref>], organic cation transporter 1 [<xref ref-type="bibr" rid="B14">14</xref>], the ABC transporter <italic>ABCC2 </italic>[<xref ref-type="bibr" rid="B15">15</xref>], <italic>ABCC6 </italic>[<xref ref-type="bibr" rid="B16">16</xref>], <italic>ABCG5 </italic>[<xref ref-type="bibr" rid="B17">17</xref>] and <italic>ABCG8 </italic>[<xref ref-type="bibr" rid="B17">17</xref>]. Although there is clear evidence for HNF4&#x003b1; to be of key importance in the control of drug metabolism it may also play a role in the regulation of transporters in the choroid plexus. Here we report our efforts in mapping HNF4&#x003b1; to human and rat choroid plexus. We determined HNF4&#x003b1; DNA binding activity and searched for transcript expression of various <italic>ABCB </italic>and <italic>ABCC </italic>transporters in the human choroid plexus. Apart from qRT-PCR and immunohistochemistry studies we evidence <italic>ABCC1 </italic>gene expression to be highly dependent on HNF4&#x003b1; as determined in functional knock down studies. Overall, we provide evidence for HNF4&#x003b1; to be an important regulator of ABC drug transporters in the choroid plexus and thus may impact efficacy of pharmacotherapy targeted to the brain.</p></sec><sec><title>Results</title><p>Initially, we searched for <italic>HNF4&#x003b1; </italic>transcripts in individual samples of human and rat choroid plexus and confirmed gene expression of <italic>HNF4&#x003b1; </italic>by quantitative real time RT-PCR (Figures <xref ref-type="fig" rid="F1">1A</xref>). We found <italic>HNF4&#x003b1; </italic>transcript expression in human and rat choroid plexus to account for approximately a tenth of its expression in the liver (Figures <xref ref-type="fig" rid="F1">1A</xref>). It is of considerable importance that <italic>HNF4&#x003b1; </italic>expression in the human and rat choroid plexus is restricted to P1 promoter driven isoforms (Table <xref ref-type="table" rid="T1">1</xref>). Furthermore, we studied expression of the insulin-like growth factor 2 (<italic>IGF2</italic>), transthyretin (<italic>TTR</italic>) and the transcription factor <italic>FOXJ1 </italic>to further qualify choroidal epithelial cells of the brain [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. These transcripts are specifically enriched in choroid plexus. We observed abundant expression of <italic>IGF2</italic>, <italic>TTR </italic>and <italic>FOXJ1 </italic>in human choroid plexus as compared to total brain RNA extracts (Figures <xref ref-type="fig" rid="F1">1B</xref>). There is the need to study histological well qualified tissue, as studies with total brain RNA extracts would render findings meaningless as will be discussed later on. Unfortunately, sufficient human choroid plexus tissue suitable for the harvest of nuclear protein and to perform western blotting as well as EMSA assay could not be obtained. We nonetheless demonstrate HNF4&#x003b1; protein expression by immunohistochemistry by use of a specific HNF4&#x003b1; antibody for human (Figures <xref ref-type="fig" rid="F2">2A</xref>) and rat choroid plexus (Figures <xref ref-type="fig" rid="F2">2C</xref>). To confirm specificity an excess of antigen preabsorbed to the antibody was used (Figures <xref ref-type="fig" rid="F2">2B, D</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>HNF4&#x003b1; isoform expression in human and rat choroid plexus.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Patient</bold></td><td align="left"><bold>HNF4&#x003b1;P1</bold></td><td align="left"><bold>HNF4&#x003b1;P2</bold></td></tr></thead><tbody><tr><td align="left">Patient 100-04</td><td align="left">0.0342</td><td align="left">0</td></tr><tr><td align="left">patient 44-04</td><td align="left">0.0025</td><td align="left">0</td></tr><tr><td align="left">patient 62-04</td><td align="left">0.4110</td><td align="left">0</td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="left"><bold>Animal</bold></td><td align="left"><bold>HNF4&#x003b1;P1</bold></td><td align="left"><bold>HNF4&#x003b1;P2</bold></td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="left">rat 1</td><td align="left">0.097</td><td align="left">0</td></tr><tr><td align="left">rat 2</td><td align="left">0.348</td><td align="left">0</td></tr><tr><td align="left">rat 3</td><td align="left">0.158</td><td align="left">0</td></tr></tbody></table><table-wrap-foot><p>HNF4&#x003b1;P1 and P2 gene expression was measured in human and rat choroid plexus (n = 3, respectively) by real-time quantitative RT-PCR and computed relative to expression of mitATPase6, which served as a housekeeping gene. Patient characteristics are given in Table 5. Caco-2 cells and pancreatic tissue served as controls for HNF4&#x003b1;P2 expression in human and rats, respectively.</p></table-wrap-foot></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Gene expression of HNF4&#x003b1; and different ABC transporters in the choroid plexus</bold>. Gene expression of HNF4&#x003b1; and different ABC transporters in the choroid plexus. A: HNF4&#x003b1; gene expression in human (n = 3) and rat choroid plexus (n = 3) was measured by quantitative real-time RT-PCR and determined relative to expression of mitATPase6, which served as a housekeeping gene. Expression levels were compared to liver and total brain. Mean values + SD are shown. B and C: Gene expression of FOXJ1, IGF2 and TTR (B) and of different members of the ABCB and ABCC family (C) was analyzed in human choroid plexus by quantitative real-time RT-PCR and determined relative to expression of mitATPase6, which served as a housekeeping gene. Expression levels were compared to liver (n = 4) and total brain. Mean values + SD are shown.</p></caption><graphic xlink:href="1471-2199-10-68-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Immunohistochemical detection of HNF4&#x003b1; in the choroid plexus</bold>. Slices of human (A, B) and rat (C, D) choroid plexus probes were stained with polyclonal antibodies against HNF4&#x003b1;. Arrows indicate representative HNF4&#x003b1; positive cells (A, C). To confirm specificity of the immunohistochemical localization antibodies were preabsorbed with excess of antigens for HNF4&#x003b1; (B, D). Patient identification numbers were indicated respectively and patient characteristics are given in Table 5. Magnification &#x000d7;400.</p></caption><graphic xlink:href="1471-2199-10-68-2"/></fig><p>We then analyzed expression of different members of the ABCB (MDR subfamily, multidrug resistance)/ABCC (MRP subfamily, multidrug resistance related) gene families in the human choroid plexus by quantitative real time RT-PCR and report results for n = 3 individual human choroid plexus samples. mRNA expression of <italic>ABCB4 (MDR2/3), ABCC1 (MRP1), ABCC2 (MRP2)</italic>, <italic>ABCC3 (MRP3), ABCC4 (MRP4), ABCC5 (MRP5) </italic>and <italic>ABCC6 (MRP6) </italic>was comparable to its expression level in commercially available control total human brain RNA extracts (Figures <xref ref-type="fig" rid="F1">1C</xref>). mRNA expression of <italic>ABCB1 (MDR1) </italic>determined in choroidal epithelium was lower than in human liver (n = 4) and in brain (Figures <xref ref-type="fig" rid="F1">1C</xref>).</p><p>We then searched for HNF4&#x003b1; binding sites in proximal promoter sequences (up to -7000 bp) of drug transporter coding genes. For this purpose, we used two different bioinformatic approaches (see Material and Methods section for a description of the employed algorithms). We observed three binding sites within the <italic>ABCB4 </italic>promoter, spaced approximately by 600 bp and 1600 bp and two recognition sites within the <italic>ABCC1 </italic>promoter (Table <xref ref-type="table" rid="T2">2</xref>). Predicted binding sites were confirmed by EMSA band shift assays. We used <sup>32</sup>P-labeled double-stranded DNA probes to specifically probe for HNF4&#x003b1;-sites located in the human <italic>ABCB4 </italic>(hABCB4_1, hABCB4_2 and hABCB4_3) and in the human <italic>ABCC1 </italic>(hABCC1_1, hABCC1_2) gene. Note, DNA binding of nuclear extracts to the A-site of the <italic>HNF1&#x003b1;</italic>-promoter (HNF1pro) served as a positive control. This site is an established recognition site for HNF4&#x003b1;. Unfortunately, sufficient amount of human choroid plexus suitable for the isolation of nuclear protein could not be obtained. Instead, we used nuclear extracts isolated from the human intestinal cell line Caco-2 which expresses several ABC transporter genes [<xref ref-type="bibr" rid="B20">20</xref>] and therefore is a rich source of HNF4&#x003b1; nuclear protein. Indeed, HNF4&#x003b1; protein expression in Caco-2 cells is comparable to organs such as the liver [<xref ref-type="bibr" rid="B21">21</xref>]. As depicted in Figures <xref ref-type="fig" rid="F3">3A</xref> we observed strong binding of HNF4&#x003b1; to the A-site of the <italic>HNF1&#x003b1;</italic>-promoter. We also observed strong binding of HNF4&#x003b1; to the predicted sites in the promoters of <italic>ABCB4 </italic>and <italic>ABCC1 </italic>(Figures <xref ref-type="fig" rid="F3">3A</xref>); bands could be shifted with a specific HNF4&#x003b1; antibody therefore demonstrating selectivity and specificity of the assay. Alignment of human, rat and mouse <italic>ABCB4 </italic>and <italic>ABCC1 </italic>genes did not identify common HNF4alpha binding sites. This points to differences in the molecular organization of ABC promoters in orthologous genes. HNF4alpha binding sites for the rat and mouse <italic>ABCB4 </italic>and <italic>ABCC1 </italic>genes are given in Table <xref ref-type="table" rid="T2">2</xref>, whereas the sequences of oligonucleotides to confirm the predicted sites experimentally are shown in Table <xref ref-type="table" rid="T3">3</xref>. As shown in Figures <xref ref-type="fig" rid="F3">3B</xref> and <xref ref-type="fig" rid="F3">3C</xref> EMSA band shift assays confirmed binding of HNF4&#x003b1; to rat and mouse <italic>ABCB4 </italic>and <italic>ABCC1 </italic>targeted sequences.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Predicted binding sites for HNF4&#x003b1; in ABC genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Gene name</bold></td><td align="left"><bold>Accession number</bold></td><td align="left"><bold>bp relative to transcription start site</bold></td><td align="left"><bold>Score core/matrix</bold></td><td></td></tr></thead><tbody><tr><td align="left"><bold>Human</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">ABCB4</td><td align="left">NM_000443.3</td><td align="left">-6274 to -6252</td><td align="left">V$zemlin13_11045</td><td align="left">1.000/0.896</td></tr><tr><td></td><td></td><td align="left">-4680 to -4658</td><td align="left">V$HNF4_01</td><td align="left">1.000/0.990</td></tr><tr><td></td><td></td><td></td><td align="left">V$zemlin13_1104</td><td align="left">1.000/0.997</td></tr><tr><td></td><td></td><td align="left">-4063 to -4041</td><td align="left">V$HNF4_01</td><td align="left">1.000/0.954</td></tr><tr><td></td><td></td><td></td><td align="left">V$zemlin13_11045</td><td align="left">1.000/0.958</td></tr><tr><td align="left">ABCC1</td><td align="left">NM_004996.3</td><td align="left">-1756 to -1734</td><td align="left">V$HNF4_01</td><td align="left">0.915/0.925</td></tr><tr><td></td><td></td><td align="left">-5266 to -5244</td><td align="left">V$HNF4_01</td><td align="left">1.000/0.944</td></tr><tr><td></td><td></td><td></td><td align="left">V$zemlin13_11045</td><td align="left">1.000/0.969</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><bold>Rat</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">ABCB4</td><td align="left">NM_012690.1</td><td align="left">-4584 to -4562</td><td align="left">V$zemlin13_11045</td><td align="left">1.000/0.894</td></tr><tr><td></td><td></td><td align="left">-39 to -17</td><td align="left">V$HNF4_01</td><td align="left">1.000/0.943</td></tr><tr><td></td><td></td><td></td><td align="left">V$zemlin13_11045</td><td align="left">1.000/0.978</td></tr><tr><td align="left">ABCC1</td><td align="left">NM_022281.2</td><td align="left">-2146 to -2124</td><td align="left">V$HNF4_01</td><td align="left">1.000/0.908</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="left"><bold>Mouse</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">ABCB4</td><td align="left">NM_008830.2</td><td align="left">-5281 to -5259</td><td align="left">V$zemlin13_11045</td><td align="left">1.000/0.907</td></tr><tr><td align="left">ABCC1</td><td align="left">NM_008576.2</td><td align="left">+2626 to +2648 (Intron 1)</td><td align="left">V$HNF4_01</td><td align="left">1.000/0.924</td></tr><tr><td></td><td></td><td></td><td align="left">V$zemlin13_11045</td><td align="left">1.000/0.910</td></tr></tbody></table><table-wrap-foot><p>Transfac matrix (V$HNF4_01) or self-generated matrix (V$zemlin13_11045) with a setting of core and matrix similarity 0.9 was used.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Shift-probes sequences.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Gene</bold></td><td align="left"><bold>Oligo name</bold></td><td align="left"><bold>Sequence</bold></td></tr></thead><tbody><tr><td align="left"><bold>Human</bold></td><td></td><td></td></tr><tr><td align="left">HNF1&#x003b1;</td><td align="left">HNF1pro</td><td align="left">AGGGCTGA <bold><underline>AGTCCA</underline> A <underline>AGTTCA </underline></bold>GTCCCTTC</td></tr><tr><td align="left">ABCB4</td><td align="left">hABCB4_1 (GS49)</td><td align="left">AGAA <bold><underline>AGGTCA</underline> A <underline>AGGCAA </underline></bold>AGCA</td></tr><tr><td></td><td align="left">hABCB4_2 (GS50)</td><td align="left">GTGC <bold><underline>AGGGCA</underline> A <underline>AGGTCA </underline></bold>GATT</td></tr><tr><td></td><td align="left">hABCB4_3 (GS51)</td><td align="left">GCTA <bold><underline>AGTCCA</underline> A <underline>AGATCA </underline></bold>ATTC</td></tr><tr><td align="left">ABCC1</td><td align="left">hABCC1_1 (GS48)</td><td align="left">TTGAC <bold><underline>AGTATA</underline> A <underline>AGGTCA </underline></bold>AGCAA</td></tr><tr><td></td><td align="left">hABCC1_2 (GS171)</td><td align="left">TTCAT <bold><underline>AGAGCA</underline> A <underline>AGTACA </underline></bold>GCAAC</td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="left"><bold>Rat</bold></td><td></td><td></td></tr><tr><td align="left">ABCB4</td><td align="left">rABCB4_1 (GS166)</td><td align="left">AGAAG <bold><underline>CCCTCA</underline> A <underline>AGTCCA </underline></bold>CCTAT</td></tr><tr><td></td><td align="left">rABCB4_2 (GS167)</td><td align="left">CGCAG <bold><underline>CGAGCA</underline> A <underline>AGTCCA </underline></bold>GGTCT</td></tr><tr><td align="left">ABCC1</td><td align="left">rABCC1_1 (GS169)</td><td align="left">GACAC <bold><underline>GGGCCA</underline> A <underline>AGACCC </underline></bold>ACAGA</td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="left"><bold>Mouse</bold></td><td></td><td></td></tr><tr><td align="left">ABCB4</td><td align="left">mABCB4_1 (GS168)</td><td align="left">ATAGC <bold><underline>CATGCA</underline> A <underline>AGTCCA </underline></bold>AAAGA</td></tr><tr><td align="left">ABCC1</td><td align="left">mABCC1_1 (GS170)</td><td align="left">TCCCT <bold><underline>TGTGCA</underline> A <underline>AGGTCT </underline></bold>AGGAT</td></tr></tbody></table><table-wrap-foot><p>The central five nucleotides of the HNF4&#x003b1; binding site are highlighted in bold letters. The two direct repeats (DR1) separated by a spacer of one nucleotide are underlined.</p></table-wrap-foot></table-wrap><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>HNF4&#x003b1; binding to promoters of ABCB4 and ABCC1</bold>. Electrophoretic mobility shift assays with 2,5 &#x003bc;g Caco-2 cell nuclear extract and oligonucleotides corresponding to the A-site of the HNF1&#x003b1; promoter (HNF1pro) and to putative HNF4&#x003b1; binding-sites within human (A), rat (B) and mouse (C) ABCB4 and ABCC1 as <sup>32</sup>P labeled probe. In supershift assays an antibody directed against HNF4&#x003b1; (+) was added. For oligonucleotide sequence information see Table 2 and 3.</p></caption><graphic xlink:href="1471-2199-10-68-3"/></fig><p>To further probe for the role of HNF4&#x003b1; in ABC gene regulation we employed an siRNA approach. Specifically, siRNA-mediated functional knock down of HNF4&#x003b1; in the human Caco-2 cell line resulted in significantly decreased gene expression of <italic>ABCC1 </italic>(Table <xref ref-type="table" rid="T4">4</xref>; for transfection efficiency and stable expression of <italic>mitATPase6 </italic>after transfection see Niehof and Borlak, 2008 [<xref ref-type="bibr" rid="B22">22</xref>]). These results confirm <italic>ABCC1 </italic>to be a gene target of HNF4&#x003b1;. <italic>ABCB4 </italic>expression in Caco-2 cells is near the limit of detection. Consequently, knockdown experiments are not meaningful.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Functional knock down of HNF4&#x003b1; in cultures of human Caco-2 cells.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Gene</bold></td><td align="left"><bold>Gene expression 48 h after HNF4&#x003b1; siRNA transfection [%]</bold></td><td align="left"><bold>p-value</bold>*</td></tr></thead><tbody><tr><td align="left">HNF4&#x003b1;</td><td align="left">24.0</td><td align="left">0.0031</td></tr><tr><td colspan="3"><hr></hr></td></tr><tr><td align="left">ABCC1</td><td align="left">56.4</td><td align="left">0.0478</td></tr></tbody></table><table-wrap-foot><p>Functional knock down of HNF4&#x003b1; was already reported [<xref ref-type="bibr" rid="B22">22</xref>]. * A student's t test was done to compare HNF4&#x003b1; siRNA transfection against negative siRNA transfected controls. The results were considered significant when the p value was less than 0.05. Gene expression was determined by real-time quantitaive RT-PCR in triplicates; mitATPase6 served as housekeeping gene. The &#x00394;&#x00394;C<sub>T</sub>-method was used to determine repression of gene expression. Values for HNF4&#x003b1; siRNA transfection represent transcript abundance relative to negative siRNA transfected controls, which were set to 100%.</p></table-wrap-foot></table-wrap></sec><sec><title>Discussion</title><p>Our study aimed for a better understanding of the role of HNF4&#x003b1; in the regulation of drug transporters. Here we present evidence for expression of HNF4&#x003b1; in the epithelium of the CSF barrier. By applying position weight matrices to genomic sequences of ABC transporters we were able to predict HNF4&#x003b1; binding sites in the promoters of the <italic>ABCB4 </italic>and <italic>ABCC1 </italic>gene. The predicted binding sites were then confirmed by EMSA band shift assays. We propose a role for HNF4&#x003b1; in the regulation of drug transporters of the choroid plexus. Notably, HNF4&#x003b1; is a key player in the regulation of genes coding for various metabolic pathways and of xenobiotic metabolism [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. This protein also promotes expression of an epithelial phenotype [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. Specifically, epithelium of the choroid plexus cells is highly differentiated and functions as a blood-CSF barrier. The expression of HNF4&#x003b1; in the epithelium of the choroid plexus and its DNA binding to regulatory sequences of drug transporters is a novel finding. Its expression accounts for approximately a tenth of HNF4&#x003b1; expression found in liver. Furthermore, there is evidence for HNF4&#x003b1; to undergo alternative splicing with isoforms may arising from alternative splicing and/or usage of two different promoters [<xref ref-type="bibr" rid="B6">6</xref>]. Specifically, the P1 promoter generates six different isoforms (HNF4&#x003b1;1-&#x003b1;6); but activation of the P2 promoter results in isoforms HNF4&#x003b1;7-&#x003b1;9. P2 promoter-driven HNF4&#x003b1; isoforms are expressed throughout mouse liver development, but disappear after birth, while P1 promoter-driven transcripts are abundantly expressed postnataly [<xref ref-type="bibr" rid="B28">28</xref>]. Additionally, P2 isoforms are induced in mouse and human hepatocellular carcinoma [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>] and are primarily expressed in human pancreatic islets and exocrine cells [<xref ref-type="bibr" rid="B31">31</xref>]. In the case of the choroid plexus it appears that expression of HNF4&#x003b1; is restricted to P1 promoter-driven isoforms. HNF4&#x003b1; protein expression in human and rat choroid plexus could be clearly evidenced by immunohistochemistry. To further qualify tissue preparations of choroid plexus expression of <italic>IGF2, TTR </italic>and <italic>FOXJ1 </italic>was investigated; their expression are accepted genetic markers of the choroid plexus [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. We validated tissue preparations by morphological and genetic markers. Unlike previous studies where expression of <italic>HNF4&#x003b1; </italic>transcripts could not be evidenced in total RNA extracts of the brain [<xref ref-type="bibr" rid="B6">6</xref>], we were able to confirm expression of <italic>HNF4&#x003b1; </italic>in the choroid plexus of human and rat brain. Most certainly, total brain RNA extracts dilute copy number of <italic>HNF4&#x003b1; </italic>transcripts to presumable levels below the limit of detection. Here, we evidence binding of HNF4&#x003b1; to regulatory sequences of drug transporters expressed in the choroid plexus and analyzed gene expression of ABC transporters in patients with different causes of death, but the functional significance of the newly identified HNF4&#x003b1; binding sites in activating the ABCB4 and ABCC1 promoters still needs to be established.</p><p>In the past attempts to detect HNF4&#x003b1; DNA binding in a choroid plexus papilloma failed [<xref ref-type="bibr" rid="B32">32</xref>]. The investigators performed EMSA experiments with nuclear extracts of rat liver, kidney and intestine and of SV40-induced choroid plexus papilloma of transgenic mice, but unfortunately probed for HNF4alpha binding with an oligonucleotide corresponding to the HNF4&#x003b1; binding site in the mouse TTR (transthyretin) promoter. The authors did not employ an antibody in EMSA band shift assays; instead, competition with excess of unlabeled probes was done. Although the authors described a weak binding of HNF4&#x003b1; with nuclear extracts from kidney they considered intestine as well as choroid plexus as deficient for HNF4&#x003b1; binding. There is a need to consider tissue specific DNA binding activity. HNF4&#x003b1; binding at the TTR promoter is much less as compared to the A-site in the HNF1 promoter (not exceeding a tenth, data not shown). As detailed above, HNF4&#x003b1; gene expression in human and rat choroid plexus is approximately one tenth of its expression in the liver (see Figures <xref ref-type="fig" rid="F1">1A</xref>). It is therefore not surprising that previous investigators [<xref ref-type="bibr" rid="B32">32</xref>] failed to detect HNF4&#x003b1; protein in intestine and choroid plexus, even though the authors described weak expression of this protein in kidney. By now, it is well established that HNF4&#x003b1; expression is not restricted to liver, but also functions in kidney and intestine [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Here we evidence by immunohistochemical staining HNF4&#x003b1; to be expressed in epithelium of human and rat choroid plexus (see Figures <xref ref-type="fig" rid="F2">2</xref>).</p><p>Notably, the choroid plexus functions as a barrier for drug uptake to the brain. This tissue expresses drug metabolizing enzymes (DMEs) and some transporters [<xref ref-type="bibr" rid="B1">1</xref>]. Expression of DMEs in the choroid plexus is part of a defense program to prevent entry of xenobiotics into the brain. The blood-CSF barrier also regulates entry and distribution of various pharmacologically active compounds between the blood and the CSF interface and is basically involved in numerous exchange processes thereby determining the supply of the brain with nutrients and hormones [<xref ref-type="bibr" rid="B1">1</xref>]. Indeed, endogenous metabolites, as well as neurotransmitter and metabolites from the brain are cleared via this barrier [<xref ref-type="bibr" rid="B19">19</xref>]. In drug therapies efflux transporters of the ABC-family are of pivotal importance in determining therapeutic tissue levels. In the past research focused on their regulation in liver, kidney and intestine [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. The knowledge on drug transporter in specialized tissues of the brain is incomplete. Specifically, ABCB (MDR) proteins accept a broad range of substrates and may transport large lipophilic, neutral or cationic compounds. This includes a vast number of neuropharmacological drugs such as antiepileptic and antiviral drugs, antidepressants, opiods, antipsychotics and tranquilizer [<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B40">40</xref>]. <italic>ABCB1</italic>, a transporter with highest expression in the gastrointestinal tract [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B41">41</xref>], is expressed at low levels in human choroid plexus, that is much lower than in liver and total brain. Our findings are consistent with results reported previously for rats [<xref ref-type="bibr" rid="B42">42</xref>]. Its apical expression in rat, mouse and human choroidal epithelium was shown previously [<xref ref-type="bibr" rid="B43">43</xref>]. Furthermore, <italic>ABCB4 </italic>is highly expressed in the liver, where it is acting as a "flippase" in transporting phospholipids into the bile, but ABCB4 can also bind and transport a subset of ABCB1 substrates with an overlap in substrate specificity [<xref ref-type="bibr" rid="B44">44</xref>]. As reported for <italic>ABCB1, ABCB4 </italic>is expressed at low levels in human choroid plexus, i.e. more than 500 fold lower than in liver. Low <italic>ABCB4 </italic>expression was also evidenced in choroidal epithelium of the rat [<xref ref-type="bibr" rid="B42">42</xref>], but to the best of our knowledge our study is the first report on expression in human choroid plexus. An apical distribution of ABCB1 in neonatal cultured rat choroid plexus cells imply a drug transport from blood into CSF [<xref ref-type="bibr" rid="B43">43</xref>]. In endothelial cells of small blood capillaries of the blood-brain barrier, apical located ABCB1 pumps drugs back into the blood stream and therefore limits drug penetration to the brain [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>Likewise, the ABCC (MRP) proteins are multispecific organic anion transporters and accept glucurono-, glutathione- and sulfo-conjugates. They transport physiological substrate conjugates as well as drug conjugates. Expression of <italic>ABCC1-6 </italic>mRNA transcripts was reported for rat choroid plexus [<xref ref-type="bibr" rid="B42">42</xref>] as was expression of <italic>ABCC1 </italic>for human choroid plexus [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>]. <italic>ABCC1, ABCC4 </italic>and <italic>ABCC5 </italic>were expressed in human choroid plexus at least at 10 fold higher than in liver; whereas <italic>ABCC2, ABCC3 </italic>and <italic>ABCC6 </italic>were expressed up to 800 fold lower than liver. Similar results were reported for <italic>ABCC </italic>transporter expression in rat choroid plexus [<xref ref-type="bibr" rid="B42">42</xref>]. Notably, ABCC1 is localized at the basolateral membrane of choroid plexus [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>], but Gazzin et al [<xref ref-type="bibr" rid="B46">46</xref>] described a major difference in the localization of ABCB1 and ABCC1 proteins between the blood-brain and the blood-CSF barrier with strongest expression of ABCC1 at the choroidal epithelium. Indeed, ABCC proteins contribute to the protective role of the choroid plexus and mediate basolateral efflux of conjugates resulting from choroidal drug metabolism into the blood. Although it is known that the choroid plexus is important in regulating the distribution of various pharmacologically active compounds between the blood and the CSF, the characterization of the involved human ABC transporters gives new insights into the function of the CSF barrier.</p><p>Furthermore, ABCBs (MDRs) and ABCCs (MRPs) are inducible transporters and are highly responsive to chemotherapeutics, carcinogens, inflammation, heat shock, hypoxia and irradiation [<xref ref-type="bibr" rid="B47">47</xref>]. They are regulated by a complex network of transcriptional cascades, such as by multiple ligand activated nuclear receptors like retinoid X receptor (RXR), farnesoid X receptor (FXR), constitutive androstane receptor (CAR) and the xenobiotic receptor pregnane X receptor (PXR) [<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>]. There is also evidence for the transcription factors AP-1, p53, Egr-1 and WT-1 to participate in their regulation with NF-Y, Sp1 and Sp3 being involved in the constitutive expression [<xref ref-type="bibr" rid="B47">47</xref>]. Recently, an upregulation of <italic>ABCB1, ABCB4 </italic>and <italic>ABCC4 </italic>transcripts was reported in human embryonic kidney cells that conditionally expressed wild-type HNF4&#x003b1; [<xref ref-type="bibr" rid="B33">33</xref>]. An important role of HNF4&#x003b1; in the transcriptional control of drug transporters was reported for human hepatocytes as determined by adenoviral HNF4&#x003b1;-siRNA mediated knockdown [<xref ref-type="bibr" rid="B49">49</xref>]. We also employed an siRNA mediated functional knockdown of HNF4&#x003b1; and found ABCC1 gene expression to be massively repressed. There is a need to improve an understanding of the mechanism by which transporters are regulated. This will impact the design of novel CNS therapeutics. Targeting transporters may thus be useful in achieving therapeutic tissue levels of CNS drugs.</p></sec><sec><title>Conclusion</title><p>We report expression of HNF4&#x003b1; in choroid plexus of the human and rat brain. This factor might regulate expression of some ATP binding cassette transporters. Targeting of HNF4&#x003b1; may impact efficacy of pharmacotherapy of CNS drugs.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Human and rat tissue</title><p>A total of n = 7 human and n = 7 rat tissues were analyzed. Samples of human choroid plexus (n = 3, gene expression analysis) were kindly provided by T. Arendt (Department of Neuroanatomy, Paul-Flechsig-Institute, University of Leipzig, Germany). Paraffin-embedded slices of human choroid plexus for immunohistochemistry (n = 4) were kindly provided by C. Grothe (Institute of Neuroanatomy, Hannover Medical School, Hannover, Germany). Human liver tissue (gene expression analysis) was obtained from patients undergoing hepatic resections and were kindly provided by J. Klempnauer (Department of Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany). Patient characteristics are given in Table <xref ref-type="table" rid="T5">5</xref>. Control human brain RNA was purchased from BD Biosciences (Heidelberg, Germany).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Patient characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Liver</bold></td><td></td><td></td><td></td><td></td><td></td></tr></thead><tbody><tr><td align="left"><bold>Patient Identification</bold></td><td align="left"><bold>Sex</bold></td><td align="left"><bold>Age</bold></td><td align="left"><bold>Information</bold></td><td align="left"><bold>Tissue</bold></td><td align="left"><bold>Application</bold></td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">P29</td><td align="left">F</td><td align="left">40</td><td align="left">Colorectal liver metastasis</td><td align="left">Healthy tissue from liver resection</td><td align="left">Gene expression analysis, comparison to choroid plexus</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">P2</td><td align="left">F</td><td align="left">70</td><td align="left">Hepatocellular carcinoma</td><td align="left">Healthy tissue from liver resection</td><td align="left">Gene expression analysis, comparison to choroid plexus</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">P3</td><td align="left">F</td><td align="left">57</td><td align="left">Hepatocellular carcinoma</td><td align="left">Healthy tissue from liver resection</td><td align="left">Gene expression analysis, comparison to choroid plexus</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">P4</td><td align="left">M</td><td align="left">67</td><td align="left">Hepatocellular carcinoma</td><td align="left">Healthy tissue from liver resection</td><td align="left">Gene expression analysis, comparison to choroid plexus</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left"><bold>Choroid Plexus</bold></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left"><bold>Patient Identification</bold></td><td align="left"><bold>Sex</bold></td><td align="left"><bold>Age</bold></td><td align="left"><bold>Cause of death</bold></td><td align="left"><bold>Tissue</bold></td><td align="left"><bold>Application</bold></td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">44-04</td><td align="left">F</td><td align="left">63</td><td align="left">liver cirrhosis</td><td align="left">38 h post mortem</td><td align="left">Gene expression analysis</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">62-04</td><td align="left">F</td><td align="left">79</td><td align="left">ovarial carcinoma</td><td align="left">33 h post mortem</td><td align="left">Gene expression analysis</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">100-04</td><td align="left">M</td><td align="left">74</td><td align="left">Acute myocardial infarction</td><td align="left">48 h post mortem</td><td align="left">Gene expression analysis</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">H5</td><td align="left">M</td><td align="left">53</td><td align="left">Circulatory failure, liver cirrhosis</td><td align="left">Choroid plexus</td><td align="left">Paraffin-embedded slices for immunohistochemistry</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">H40</td><td align="left">M</td><td align="left">32</td><td align="left">Circulatory failure, endocarditis</td><td align="left">Choroid plexus</td><td align="left">Paraffin-embedded slices for immunohistochemistry</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">H54</td><td align="left">M</td><td align="left">59</td><td align="left">Respiratory insufficiency, pneunomia</td><td align="left">Choroid plexus</td><td align="left">Paraffin-embedded slices for immunohistochemistry</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="left">H55</td><td align="left">M</td><td align="left">81</td><td align="left">Circulatory failure, generalized artheriosclerosis</td><td align="left">Choroid plexus</td><td align="left">Paraffin-embedded slices for immunohistochemistry</td></tr></tbody></table></table-wrap><p>Samples of rat choroid plexus (n = 3, Sprague Dawley rats, gene expression analysis) were kindly provided by H. Hilbig and K. Spanel-Borowski (Department of Anatomy, University of Leipzig, Germany). Samples of rat liver and brain (Sprague Dawley rats, gene expression analysis) were generated in-house. Paraffin-embedded slices of rat brain (Sprague Dawley rats) containing choroid plexus regions for immunohistochemistry (n = 4) were kindly provided by C. Grothe (Institute of Neuroanatomy, Hannover Medical School, Hannover, Germany).</p></sec><sec><title>Quantitative real-time RT-PCR</title><p>Analysis of human samples: Three human choroid plexus samples and four human liver samples were analyzed separately and used for calculation of the mean and standard deviation. Analysis of rat samples: Three rat choroid plexus samples, three rat liver and three rat brain samples were analyzed separately and used for calculation of the mean and standard deviation. Total RNA from choroid plexus and liver was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturers recommendations. Subsequently to RNA isolation, a DNase I digest was performed. 4 &#x003bc;g total RNA from each sample was used for reverse transcription (Omniscript Reverse Transcriptase, Qiagen, Hilden, Germany). Quantitative real-time RT-PCR measurement was done with the Lightcycler (Roche Diagnostics, Mannheim, Germany) with the following conditions: denaturation at 95&#x000b0;C, annealing at different temperatures for 8 sec, extension at 72&#x000b0;C for different times and detection of SYBR-Green I-fluorescence at different temperatures. Detailed primer specific conditions and oligonucleotide sequence information are given in Table <xref ref-type="table" rid="T6">6</xref>. Relative quantification was performed using the "Fit Points Method" of the LightCycler3 Data Analysis Software version 3.5.28 (Roche Diagnostics, Mannheim, Germany) by comparing the sample values to a standard curve within the linear range of amplification. This comparison was performed during each LightCycler Run (for genes of interest as well as for the housekeeping gene, i.e. mitATPase6). The standardized sample values for each gene of interest were divided by the standardized values of the housekeeping gene. The slope of external standard curves are given in Table <xref ref-type="table" rid="T6">6</xref>, indicating the PCR efficiency for each amplicon.</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>Real-time PCR primer sequences and amplification settings.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Gene</bold></td><td align="left"><bold>Accession number</bold></td><td align="left"><bold>Species</bold></td><td align="left"><bold>Primer sequence</bold></td><td align="left"><bold>Fragment length</bold></td><td align="left"><bold>Annealing</bold></td><td align="left"><bold>Extension</bold></td><td align="left"><bold>Fluorescence</bold></td><td align="left"><bold>Slope</bold></td></tr></thead><tbody><tr><td align="left">HNF4&#x003b1;</td><td align="left">NM_000457</td><td align="left">human</td><td align="left">fwd:CTGCTCGGAGCCACCAAGAGATCCATG</td><td align="left">371 bp</td><td align="left">60&#x000b0;C</td><td align="left">15 sec</td><td align="left">88&#x000b0;C</td><td align="left">-3.629</td></tr><tr><td></td><td></td><td></td><td align="left">rev: ATCATCTGCCAGGTGATGCTCTGCA</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">HNF4&#x003b1;P1</td><td align="left">NM_178849</td><td align="left">human</td><td align="left">fwd: GAATGCGACTCTCCAAAACC</td><td align="left">339 bp</td><td align="left">68&#x000b0;C</td><td align="left">14 sec</td><td align="left">88&#x000b0;C</td><td align="left">-3.058</td></tr><tr><td></td><td align="left">NM_178850</td><td></td><td align="left">rev: GGCACTGGTTCCTCTTGTCT</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td align="left">NM_000457</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">HNF4&#x003b1;P2</td><td align="left">NM_001030003</td><td align="left">human</td><td align="left">fwd: GGGCTCCAGTGGAGAGTTC</td><td align="left">342 bp</td><td align="left">68&#x000b0;C</td><td align="left">14 sec</td><td align="left">88&#x000b0;C</td><td align="left">-2.648</td></tr><tr><td></td><td></td><td></td><td align="left">rev: CATAGCTTGACCTTCGAGTGC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">FOXJ1</td><td align="left">NM_001454</td><td align="left">human</td><td align="left">fwd: CTACTCGTATGCCACGCTCA</td><td align="left">183 bp</td><td align="left">60&#x000b0;C</td><td align="left">8 sec</td><td align="left">86&#x000b0;C</td><td align="left">-3.459</td></tr><tr><td></td><td></td><td></td><td align="left">rev: CGAGGCACTTTGATGAAGC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">IGF2</td><td align="left">NM_000162</td><td align="left">human</td><td align="left">fwd: GGTGCTTCTCACCTTCTTGG</td><td align="left">298 bp</td><td align="left">68&#x000b0;C</td><td align="left">12 sec</td><td align="left">90&#x000b0;C</td><td align="left">-2.724</td></tr><tr><td></td><td></td><td></td><td align="left">rev: GGGGTATCTGGGGAAGTTGT</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">TTR</td><td align="left">NM_000371</td><td align="left">human</td><td align="left">fwd: CAGAAAGGCTGCTGATGACA</td><td align="left">261 bp</td><td align="left">60&#x000b0;C</td><td align="left">11 sec</td><td align="left">86&#x000b0;C</td><td align="left">-3.438</td></tr><tr><td></td><td></td><td></td><td align="left">rev: GCCGTGGTGGAATAGGAGTA</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCB1</td><td align="left">NM_000927</td><td align="left">human</td><td align="left">fwd: AAAAAGATCAACTCGTAGGAGTG</td><td align="left">161 bp</td><td align="left">60&#x000b0;C</td><td align="left">7 sec</td><td align="left">81&#x000b0;C</td><td align="left">-3.331</td></tr><tr><td></td><td></td><td></td><td align="left">rev: GCACAAAATACACCAACAA</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCB4</td><td align="left">NM_000443</td><td align="left">human</td><td align="left">fwd: CCACAGCGAACTGATGAAGA</td><td align="left">301 bp</td><td align="left">68&#x000b0;C</td><td align="left">13 sec</td><td align="left">83&#x000b0;C</td><td align="left">-3.826</td></tr><tr><td></td><td></td><td></td><td align="left">rev: CACGACAAAGTAGGGCCATT</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCC1</td><td align="left">NM_004996</td><td align="left">human</td><td align="left">fwd: AGTCCCCACAGAAGGAGTGG</td><td align="left">358 bp</td><td align="left">60&#x000b0;C</td><td align="left">15 sec</td><td align="left">87&#x000b0;C</td><td align="left">-3.639</td></tr><tr><td></td><td></td><td></td><td align="left">rev: TCCCCGACCGTGGAGGATTT</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCC2</td><td align="left">NM_000392</td><td align="left">human</td><td align="left">fwd: CCGTATCAGGTTTGCCAGTT</td><td align="left">312 bp</td><td align="left">60&#x000b0;C</td><td align="left">13 sec</td><td align="left">84&#x000b0;C</td><td align="left">-3.756</td></tr><tr><td></td><td></td><td></td><td align="left">rev: CAACAGCCACAATGTTGGTC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCC3</td><td align="left">NM_003786</td><td align="left">human</td><td align="left">fwd: CTCAATGTGGCAGACATCGG</td><td align="left">177 bp</td><td align="left">60&#x000b0;C</td><td align="left">8 sec</td><td align="left">87&#x000b0;C</td><td align="left">-3.731</td></tr><tr><td></td><td></td><td></td><td align="left">rev: GGGAGCTCACAAACGTGTGC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCC4</td><td align="left">NM_005845</td><td align="left">human</td><td align="left">fwd CTTGGAGAGGAGTTGCAAGG</td><td align="left">236 bp</td><td align="left">68&#x000b0;C</td><td align="left">10 sec</td><td align="left">78&#x000b0;C</td><td align="left">-4.479</td></tr><tr><td></td><td align="left">NM_001105515</td><td></td><td align="left">rev: GCTGTGTTCAAAGCCACAGA</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCC5</td><td align="left">NM_005688</td><td align="left">human</td><td align="left">fwd: CCTGTTTGGGAAGGAATATGA</td><td align="left">203 bp</td><td align="left">60&#x000b0;C</td><td align="left">9 sec</td><td align="left">88&#x000b0;C</td><td align="left">-3.446</td></tr><tr><td></td><td></td><td></td><td align="left">rev: CCTGTTTGGGAAGGAATATGA</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">ABCC6</td><td align="left">NM_001171</td><td align="left">human</td><td align="left">fwd: TTCTCTGTGTCGCTGGTGTC</td><td align="left">309 bp</td><td align="left">60&#x000b0;C</td><td align="left">13 sec</td><td align="left">87&#x000b0;C</td><td align="left">-2.982</td></tr><tr><td></td><td></td><td></td><td align="left">rev: GGCACTGTGTATGGTGATGC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">MitATPase6</td><td align="left">NC_001807</td><td align="left">human</td><td align="left">fwd: CTAAAGGACGAACCTGA</td><td align="left">315 bp</td><td align="left">55&#x000b0;C</td><td align="left">13 sec</td><td align="left">83&#x000b0;C</td><td align="left">-3.608</td></tr><tr><td></td><td></td><td></td><td align="left">rev: TGGCCTGCAGTAATGTT</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">HNF4&#x003b1;</td><td align="left">NM_022180</td><td align="left">rat</td><td align="left">fwd: GCCTGCCTCAAAGCCATCAT</td><td align="left">274 bp</td><td align="left">55&#x000b0;C</td><td align="left">11 sec</td><td align="left">88&#x000b0;C</td><td align="left">-3.697</td></tr><tr><td></td><td></td><td></td><td align="left">rev: GACCCTCCAAGCAGCATCTC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">HNF4&#x003b1;P1</td><td align="left">D10554, EF193392</td><td align="left">rat</td><td align="left">fwd: AAATGTGCAGGTGTTGACCA</td><td align="left">178 bp</td><td align="left">60&#x000b0;C</td><td align="left">7 sec</td><td align="left">87&#x000b0;C</td><td align="left">-3.296</td></tr><tr><td></td><td></td><td></td><td align="left">rev: CACGCTCCTCCTGAAGAATC</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">HNF4&#x003b1;P2</td><td align="left">AF329936</td><td align="left">rat</td><td align="left">fwd: CTCCAGTGGCGAGTCCTTAT</td><td align="left">171 bp</td><td align="left">60&#x000b0;C</td><td align="left">7 sec</td><td align="left">87&#x000b0;C</td><td align="left">-2.273</td></tr><tr><td></td><td align="left">EF193390</td><td></td><td align="left">rev: TCACGCTCCTCCTGAAGAAT</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9"><hr></hr></td></tr><tr><td align="left">MitATPase6</td><td align="left">NC_001665</td><td align="left">rat</td><td align="left">fwd: CTAAAGGACGAACCTGA</td><td align="left">315 bp</td><td align="left">55&#x000b0;C</td><td align="left">13 sec</td><td align="left">83&#x000b0;C</td><td align="left">-3.644</td></tr><tr><td></td><td></td><td></td><td align="left">rev: TGGCCTGCAGTAATGTT</td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table></table-wrap></sec><sec><title>Caco-2 cell culture</title><p>Caco-2 cells are a valuable source for HNF4&#x003b1; nuclear protein [<xref ref-type="bibr" rid="B21">21</xref>] and were obtained from and cultivated as recommended by DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany) and seeded with a density of 4 &#x000d7; 10<sup>6 </sup>cells per 75 cm<sup>2 </sup>flask and harvested after 11 days of culture.</p></sec><sec><title>Isolation of nuclear extracts</title><p>Nuclear extracts from Caco-2 cells were isolated by the modified method of Dignam et al [<xref ref-type="bibr" rid="B50">50</xref>]. Eleven days after seeding cells were washed twice with ice-cold PBS, scraped into microcentrifuge tubes and centrifuged for 5 min at 2000 &#x000d7; g, 4&#x000b0;C. Cell pellets were resuspended in lysis buffer (10 mM Tris pH 7.4, 2 mM MgCl<sub>2</sub>, 140 mM NaCl, 1 mM DTT, 4 mM Pefabloc, 1% Aprotinin, 40 mM &#x003b2;-glycerophosphate, 1 mM sodiumorthovanadate and 0.5% TX100) at 4&#x000b0;C for 10 min (300 &#x003bc;l for 1 &#x000d7; 10<sup>7 </sup>cells), transferred onto one volume of 50% sucrose in lysis buffer and centrifuged at 14000 &#x000d7; g and 4&#x000b0;C for 10 min. Nuclei were resuspended in Dignam C buffer (20 mM Hepes pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl<sub>2</sub>, 0.2 mM EDTA, 1 mM DTT, 4 mM Pefabloc, 1% Aprotinin, 40 mM &#x003b2;-glycerophosphate, 1 mM sodiumorthovanadate, 30 &#x003bc;l for 1 &#x000d7; 10<sup>7 </sup>cells) and gently shaked at 4&#x000b0;C for 30 min. Nuclear debris was removed by centrifugation at 14000 &#x000d7; g at 4&#x000b0;C for 10 min. Protein concentrations were determined according to the method of Smith <italic>et al </italic>[<xref ref-type="bibr" rid="B51">51</xref>]. The extracts were aliquoted and stored at -70&#x000b0;C.</p></sec><sec><title>Electrophoretic mobility shift assays</title><p>Forward and reverse oligonucleotides (for sequence information see Table <xref ref-type="table" rid="T3">3</xref>) were purchased from MWG Biotech (Ebersberg/Muenchen, Germany), annealed and <sup>32</sup>P-labeled using <sup>32</sup>P&#x003b3;ATP and T4-kinase (New England Biolabs, Frankfurt, Germany). 2,5 &#x003bc;g Caco-2 cell nuclear extract and 10<sup>5 </sup>cpm (0.027 ng) radiolabeled probe were incubated in binding buffer consisted of 25 mM HEPES, pH 7.6, 5 mM MgCl<sub>2</sub>, 34 mM KCl, 2 mM DTT, 2 mM Pefabloc, 2% Aprotinin, 40 ng of poly (dI-dC)/&#x003bc;l and 100 ng of bovine serum albumin/&#x003bc;l for 20 minutes on ice. Free DNA and DNA-protein complexes were resolved on a 6% polyacrylamide gel (acrylamide: bisacrylamide ratio = 37.5:1). Super shift experiments were done with a 1 &#x003bc;g HNF4&#x003b1; specific antibody (sc-6556x, Santa Cruz Biotechnology, Heidelberg, Germany). DNA binding of nuclear extracts to the A-site of the <italic>HNF1&#x003b1;</italic>-promoter (HNF1pro) served as a positive control.</p></sec><sec><title>Bioinformatic searches for HNF4&#x003b1; binding-sites</title><p>The transcription start site (TSS, +1) of the NCBI mRNA reference sequence (RefSeq) was aligned using the UCSC Genome Browser <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/"/> for promoter annotation of the respective genes. Proximal promoters (up to -7000 bp) of human ABCB1, ABCB4 and ABCC1 to ABCC6 were checked for putative HNF4&#x003b1; binding-sites with the tool MATCH [<xref ref-type="bibr" rid="B52">52</xref>], <ext-link ext-link-type="uri" xlink:href="http://www.biobase.de"/> by employing two different weight matrix, i.e. V$HNF4_01, Transfac matrix (generated by Biobase) and V$zemlin13-11045 (self-generated). V$zemlin13-11045 is based on a collection of 33 well known HNF4&#x003b1; sites and was generated using the matrix generation tool of Biobase <ext-link ext-link-type="uri" xlink:href="http://www.biobase.de"/>. At least one of both matrices has to exceed the cut-off of 0.9 for core similarity and 0.9 for matrix similarity (Table <xref ref-type="table" rid="T2">2</xref>). Furthermore, proximal promoters (up to -7000 bp) of rat and mouse ABCB4 and ABCC1 were checked for putative HNF4&#x003b1; binding sites (Table <xref ref-type="table" rid="T2">2</xref>).</p></sec><sec><title>Immunohistochemistry</title><p>The sections were deparaffinized, demasked by heating, incubated with 0,6% H<sub>2</sub>O<sub>2 </sub>in methanol for 30 min, and subsequently with protein block serum-free reagent (Dako, Glostrup, Denmark) for 10 min. Incubation with polyclonal antibody (Santa Cruz Biotechnology, Heidelberg, Germany) against HNF4&#x003b1; (sc-6556x, 1:400 dilution for rat sections, 1:200 dilution for human sections) was performed for 45 min. The sections were rinsed with Tris-buffered saline, incubated with biotinylated universal secondary antibodies (Dako, Glostrup, Denmark) for 15 min and subsequently with horseradish peroxidase-conjugated streptavidin solution (Dako, Glostrup, Denmark) for 15 min. Labeling was detected using a diaminobenzidine (DAB) chromogen solution (Dako, Glostrup, Denmark) for 5 min. The sections were counterstained with hematoxylin before examination under light microscope. To confirm the specificity of the immunohistochemical localization, antibodies preabsorbed 2 h with a twenty fold excess of antigen for HNF4&#x003b1; (sc-6556P, Santa Cruz Biotechnology, Heidelberg, Germany) were used.</p></sec><sec><title>siRNA silencing of HNF4&#x003b1;</title><p>Human HNF4&#x003b1;-specific siRNA probes were purchased from Qiagen (Hilden, Germany). Caco-2 cells (1,5 &#x000d7; 10<sup>5 </sup>cells/well in 24-well plate) were transfected in triplicate for 48 h with 25 nM of the siRNA duplex using HiPerFect transfection reagent (Qiagen, Hilden, Germany). Alexa-Fluor488 labeld siRNA (Qiagen, Hilden Germany) was used as negative siRNA and as positive control for transfection efficiency. For transfection efficiency and stable expression of mitATPase6 after transfection see Niehof and Borlak, 2008 [<xref ref-type="bibr" rid="B22">22</xref>].</p></sec></sec><sec><title>Abbreviations</title><p>ABC transporter: ATP-binding cassette transporter; CSF: cerebrospinal fluid; DME: drug metabolizing enzymes; EMSA: electrophoretic mobility shift assay; HNF: hepatocyte nuclear factor; MDR: multidrug resistance gene family (ABCB); MRP: multidrug resistance related proteins gene family (ABCC); TTR: transthyretin.</p></sec><sec><title>Authors' contributions</title><p>JB designed the entire study, supervised the experimental works and is responsible for the final writing of the manuscript, MN supervised the experiments and prepared the initial draft of the manuscript. Both authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank S. Marschke, A. Pfanne and A. Schulmeyer for valuable technical assistance, S. Reymann and R. Zemlin for assistance in bioinformatics and advice on design of PCR primers, T. Arendt, U. G&#x000e4;rtner and C. Grothe for providing samples of human choroid plexus and H. Hilbig, K. Spanel-Borowski and C. Grothe for the preparation of rat choroid plexus. This work was supported by a grant of the Lower Saxony Ministry of Culture and Science to J.B.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghersi-Egea</surname><given-names>JF</given-names></name><name><surname>Strazielle</surname><given-names>N</given-names></name></person-group><article-title>Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus</article-title><source>Microsc Res Tech</source><year>2001</year><volume>52</volume><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">11135451</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graff</surname><given-names>CL</given-names></name><name><surname>Pollack</surname><given-names>GM</given-names></name></person-group><article-title>Drug transport at the blood-brain barrier and the choroid plexus</article-title><source>Curr Drug Metab</source><year>2004</year><volume>5</volume><fpage>95</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">14965253</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schinkel</surname><given-names>AH</given-names></name><name><surname>Jonker</surname><given-names>JW</given-names></name></person-group><article-title>Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview</article-title><source>Adv Drug Deliv Rev</source><year>2003</year><volume>55</volume><fpage>3</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">12535572</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glavinas</surname><given-names>H</given-names></name><name><surname>Krajcsi</surname><given-names>P</given-names></name><name><surname>Cserepes</surname><given-names>J</given-names></name><name><surname>Sarkadi</surname><given-names>B</given-names></name></person-group><article-title>The role of ABC transporters in drug resistance, metabolism and toxicity</article-title><source>Curr Drug Deliv</source><year>2004</year><volume>1</volume><fpage>27</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">16305368</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Toyoda</surname><given-names>Y</given-names></name><name><surname>Hagiya</surname><given-names>Y</given-names></name><name><surname>Adachi</surname><given-names>T</given-names></name><name><surname>Hoshijima</surname><given-names>K</given-names></name><name><surname>Kuo</surname><given-names>MT</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name></person-group><article-title>MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions</article-title><source>Xenobiotica</source><year>2008</year><volume>38</volume><fpage>833</fpage><lpage>862</lpage><pub-id pub-id-type="pmid">18668432</pub-id></citation></ref><ref id="B6"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sladek</surname><given-names>FM</given-names></name><name><surname>Seidel</surname><given-names>SD</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Burris T, McCabe ERB</surname></name></person-group><article-title>Hepatocyte nuclear factor 4alpha</article-title><source>Nuclear Receptors and Disease</source><year>2001</year><publisher-name>Academic Press, London</publisher-name><fpage>309</fpage><lpage>361</lpage></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schrem</surname><given-names>H</given-names></name><name><surname>Klempnauer</surname><given-names>J</given-names></name><name><surname>Borlak</surname><given-names>J</given-names></name></person-group><article-title>Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression</article-title><source>Pharmacol Rev</source><year>2002</year><volume>54</volume><fpage>129</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">11870262</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parviz</surname><given-names>F</given-names></name><name><surname>Matullo</surname><given-names>C</given-names></name><name><surname>Garrison</surname><given-names>WD</given-names></name><name><surname>Savatski</surname><given-names>L</given-names></name><name><surname>Adamson</surname><given-names>JW</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis</article-title><source>Nat Genet</source><year>2003</year><volume>34</volume><fpage>292</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12808453</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jover</surname><given-names>R</given-names></name><name><surname>Bort</surname><given-names>R</given-names></name><name><surname>Gomez-Lechon</surname><given-names>MJ</given-names></name><name><surname>Castell</surname><given-names>JV</given-names></name></person-group><article-title>Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting</article-title><source>Hepatology</source><year>2001</year><volume>33</volume><fpage>668</fpage><lpage>675</lpage><pub-id pub-id-type="pmid">11230748</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>FJ</given-names></name></person-group><article-title>Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription</article-title><source>Drug Metab Pharmacokinet</source><year>2008</year><volume>23</volume><fpage>2</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18305369</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barbier</surname><given-names>O</given-names></name><name><surname>Girard</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name><name><surname>Duez</surname><given-names>H</given-names></name><name><surname>Villeneuve</surname><given-names>L</given-names></name><name><surname>Kamiya</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha</article-title><source>Mol Pharmacol</source><year>2005</year><volume>67</volume><fpage>241</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">15470081</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Echchgadda</surname><given-names>I</given-names></name><name><surname>Song</surname><given-names>CS</given-names></name><name><surname>Oh</surname><given-names>T</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name><name><surname>De</surname><given-names>LCI</given-names></name><name><surname>Chatterjee</surname><given-names>B</given-names></name></person-group><article-title>The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase</article-title><source>Mol Endocrinol</source><year>2007</year><volume>21</volume><fpage>2099</fpage><lpage>2111</lpage><pub-id pub-id-type="pmid">17595319</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Popowski</surname><given-names>K</given-names></name><name><surname>Eloranta</surname><given-names>JJ</given-names></name><name><surname>Saborowski</surname><given-names>M</given-names></name><name><surname>Fried</surname><given-names>M</given-names></name><name><surname>Meier</surname><given-names>PJ</given-names></name><name><surname>Kullak-Ublick</surname><given-names>GA</given-names></name></person-group><article-title>The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4{alpha} and suppressed by bile acids</article-title><source>Mol Pharmacol</source><year>2005</year><volume>67</volume><fpage>1629</fpage><lpage>1638</lpage><pub-id pub-id-type="pmid">15692145</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saborowski</surname><given-names>M</given-names></name><name><surname>Kullak-Ublick</surname><given-names>GA</given-names></name><name><surname>Eloranta</surname><given-names>JJ</given-names></name></person-group><article-title>The Human Organic Cation Transporter 1 Gene is Transactivated by Hepatocyte Nuclear Factor-4{alpha}</article-title><source>J Pharmacol Exp Ther</source><year>2006</year><volume>317</volume><fpage>778</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">16436500</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qadri</surname><given-names>I</given-names></name><name><surname>Hu</surname><given-names>LJ</given-names></name><name><surname>Iwahashi</surname><given-names>M</given-names></name><name><surname>Al Zuabi</surname><given-names>S</given-names></name><name><surname>Quattrochi</surname><given-names>LC</given-names></name><name><surname>Simon</surname><given-names>FR</given-names></name></person-group><article-title>Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2)</article-title><source>Toxicol Appl Pharmacol</source><year>2009</year><volume>234</volume><fpage>281</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">19010343</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Douet</surname><given-names>V</given-names></name><name><surname>VanWart</surname><given-names>CM</given-names></name><name><surname>Heller</surname><given-names>MB</given-names></name><name><surname>Reinhard</surname><given-names>S</given-names></name><name><surname>Le Saux</surname><given-names>O</given-names></name></person-group><article-title>HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression</article-title><source>Biochim Biophys Acta</source><year>2006</year><volume>1759</volume><fpage>426</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">16997394</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sumi</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Uchida</surname><given-names>A</given-names></name><name><surname>Magoori</surname><given-names>K</given-names></name><name><surname>Urashima</surname><given-names>Y</given-names></name><name><surname>Ohashi</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>4248</fpage><lpage>4260</lpage><pub-id pub-id-type="pmid">17403900</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Costa</surname><given-names>RH</given-names></name></person-group><article-title>The winged helix transcription factor HFH-4 is expressed during choroid plexus epithelial development in the mouse embryo</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>3094</fpage><lpage>3099</lpage><pub-id pub-id-type="pmid">9096351</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strazielle</surname><given-names>N</given-names></name><name><surname>Ghersi-Egea</surname><given-names>JF</given-names></name></person-group><article-title>Choroid plexus in the central nervous system: biology and physiopathology</article-title><source>J Neuropathol Exp Neurol</source><year>2000</year><volume>59</volume><fpage>561</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">10901227</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borlak</surname><given-names>J</given-names></name><name><surname>Zwadlo</surname><given-names>C</given-names></name></person-group><article-title>Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco-2 cells</article-title><source>Xenobiotica</source><year>2003</year><volume>33</volume><fpage>927</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">14514442</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niehof</surname><given-names>M</given-names></name><name><surname>Borlak</surname><given-names>J</given-names></name></person-group><article-title>RSK4 and PAK5 Are Novel Candidate Genes in Diabetic Rat Kidney and Brain</article-title><source>Mol Pharmacol</source><year>2005</year><volume>67</volume><fpage>604</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">15615695</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niehof</surname><given-names>M</given-names></name><name><surname>Borlak</surname><given-names>J</given-names></name></person-group><article-title>HNF4{alpha} and the Ca-Channel TRPC1 Are Novel Disease Candidate Genes in Diabetic Nephropathy</article-title><source>Diabetes</source><year>2008</year><volume>57</volume><fpage>1069</fpage><lpage>1077</lpage><pub-id pub-id-type="pmid">18184923</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayhurst</surname><given-names>GP</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Lambert</surname><given-names>G</given-names></name><name><surname>Ward</surname><given-names>JM</given-names></name><name><surname>Gonzalez</surname><given-names>FJ</given-names></name></person-group><article-title>Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis</article-title><source>Mol Cell Biol</source><year>2001</year><volume>21</volume><fpage>1393</fpage><lpage>1403</lpage><pub-id pub-id-type="pmid">11158324</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odom</surname><given-names>DT</given-names></name><name><surname>Zizlsperger</surname><given-names>N</given-names></name><name><surname>Gordon</surname><given-names>DB</given-names></name><name><surname>Bell</surname><given-names>GW</given-names></name><name><surname>Rinaldi</surname><given-names>NJ</given-names></name><name><surname>Murray</surname><given-names>HL</given-names></name><etal></etal></person-group><article-title>Control of Pancreas and Liver Gene Expression by HNF Transcription Factors</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1378</fpage><lpage>1381</lpage><pub-id pub-id-type="pmid">14988562</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>H</given-names></name><name><surname>Gotoh</surname><given-names>T</given-names></name><name><surname>Kojima</surname><given-names>T</given-names></name><name><surname>Satohisa</surname><given-names>S</given-names></name><name><surname>Kikuchi</surname><given-names>K</given-names></name><name><surname>Osanai</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells</article-title><source>Exp Cell Res</source><year>2003</year><volume>286</volume><fpage>288</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">12749857</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiba</surname><given-names>H</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Satohisa</surname><given-names>S</given-names></name><name><surname>Sakai</surname><given-names>N</given-names></name><name><surname>Noguchi</surname><given-names>H</given-names></name><name><surname>Osanai</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Activation of p21(CIP1/WAF1) gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4alpha</article-title><source>Exp Cell Res</source><year>2005</year><volume>302</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">15541721</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Battle</surname><given-names>MA</given-names></name><name><surname>Konopka</surname><given-names>G</given-names></name><name><surname>Parviz</surname><given-names>F</given-names></name><name><surname>Gaggl</surname><given-names>AL</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Sladek</surname><given-names>FM</given-names></name><etal></etal></person-group><article-title>Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>8419</fpage><lpage>8424</lpage><pub-id pub-id-type="pmid">16714383</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torres-Padilla</surname><given-names>ME</given-names></name><name><surname>Fougere-Deschatrette</surname><given-names>C</given-names></name><name><surname>Weiss</surname><given-names>MC</given-names></name></person-group><article-title>Expression of HNF4alpha isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3' end splicing</article-title><source>Mech Dev</source><year>2001</year><volume>109</volume><fpage>183</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">11731232</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Niehof</surname><given-names>M</given-names></name><name><surname>Borlak</surname><given-names>J</given-names></name></person-group><article-title>EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas</article-title><source>Gastroenterology</source><year>2008</year><volume>134</volume><fpage>1191</fpage><lpage>1202</lpage><pub-id pub-id-type="pmid">18395097</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Hotta</surname><given-names>H</given-names></name><name><surname>Takano</surname><given-names>K</given-names></name><name><surname>Iwanari</surname><given-names>H</given-names></name><name><surname>Sumi</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer</article-title><source>J Pathol</source><year>2006</year><volume>208</volume><fpage>662</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">16400631</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>SK</given-names></name><name><surname>Parrizas</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>ML</given-names></name><name><surname>Pruhova</surname><given-names>S</given-names></name><name><surname>Ek</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Genetic evidence that HNF-1{alpha}-dependent transcriptional control of HNF-4{alpha} is essential for human pancreatic {beta} cell function</article-title><source>J Clin Invest</source><year>2002</year><volume>110</volume><fpage>827</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">12235114</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>RH</given-names></name><name><surname>Van Dyke</surname><given-names>TA</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Kuo</surname><given-names>F</given-names></name><name><surname>Darnell</surname><given-names>JE</given-names><suffix>Jr</suffix></name></person-group><article-title>Similarities in transthyretin gene expression and differences in transcription factors: liver and yolk sac compared to choroid plexus</article-title><source>Proc Natl Acad Sci USA</source><year>1990</year><volume>87</volume><fpage>6589</fpage><lpage>6593</lpage><pub-id pub-id-type="pmid">2395861</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>B</given-names></name><name><surname>Grigo</surname><given-names>K</given-names></name><name><surname>Erdmann</surname><given-names>S</given-names></name><name><surname>Lausen</surname><given-names>J</given-names></name><name><surname>Klein-Hitpass</surname><given-names>L</given-names></name><name><surname>Ryffel</surname><given-names>GU</given-names></name></person-group><article-title>HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma</article-title><source>Oncogene</source><year>2005</year><volume>24</volume><fpage>6418</fpage><lpage>6431</lpage><pub-id pub-id-type="pmid">16007190</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garrison</surname><given-names>WD</given-names></name><name><surname>Battle</surname><given-names>MA</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Kaestner</surname><given-names>KH</given-names></name><name><surname>Sladek</surname><given-names>FM</given-names></name><name><surname>Duncan</surname><given-names>SA</given-names></name></person-group><article-title>Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon</article-title><source>Gastroenterology</source><year>2006</year><volume>130</volume><fpage>1207</fpage><lpage>1220</lpage><pub-id pub-id-type="pmid">16618389</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loscher</surname><given-names>W</given-names></name><name><surname>Potschka</surname><given-names>H</given-names></name></person-group><article-title>Role of multidrug transporters in pharmacoresistance to antiepileptic drugs</article-title><source>J Pharmacol Exp Ther</source><year>2002</year><volume>301</volume><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">11907151</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Potschka</surname><given-names>H</given-names></name><name><surname>Fedrowitz</surname><given-names>M</given-names></name><name><surname>Loscher</surname><given-names>W</given-names></name></person-group><article-title>Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity</article-title><source>J Pharmacol Exp Ther</source><year>2003</year><volume>306</volume><fpage>124</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">12663688</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dagenais</surname><given-names>C</given-names></name><name><surname>Graff</surname><given-names>CL</given-names></name><name><surname>Pollack</surname><given-names>GM</given-names></name></person-group><article-title>Variable modulation of opioid brain uptake by P-glycoprotein in mice</article-title><source>Biochem Pharmacol</source><year>2004</year><volume>67</volume><fpage>269</fpage><lpage>276</lpage><pub-id pub-id-type="pmid">14698039</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El Ela</surname><given-names>AA</given-names></name><name><surname>Hartter</surname><given-names>S</given-names></name><name><surname>Schmitt</surname><given-names>U</given-names></name><name><surname>Hiemke</surname><given-names>C</given-names></name><name><surname>Spahn-Langguth</surname><given-names>H</given-names></name><name><surname>Langguth</surname><given-names>P</given-names></name></person-group><article-title>Identification of P-glycoprotein substrates and inhibitors among psychoactive compounds&#x02013;implications for pharmacokinetics of selected substrates</article-title><source>J Pharm Pharmacol</source><year>2004</year><volume>56</volume><fpage>967</fpage><lpage>975</lpage><pub-id pub-id-type="pmid">15285840</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doran</surname><given-names>A</given-names></name><name><surname>Obach</surname><given-names>RS</given-names></name><name><surname>Smith</surname><given-names>BJ</given-names></name><name><surname>Hosea</surname><given-names>NA</given-names></name><name><surname>Becker</surname><given-names>S</given-names></name><name><surname>Callegari</surname><given-names>E</given-names></name><etal></etal></person-group><article-title>The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model</article-title><source>Drug Metab Dispos</source><year>2005</year><volume>33</volume><fpage>165</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">15502009</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szakacs</surname><given-names>G</given-names></name><name><surname>Varadi</surname><given-names>A</given-names></name><name><surname>Ozvegy-Laczka</surname><given-names>C</given-names></name><name><surname>Sarkadi</surname><given-names>B</given-names></name></person-group><article-title>The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)</article-title><source>Drug Discov Today</source><year>2008</year><volume>13</volume><fpage>379</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">18468555</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>JM</given-names></name><name><surname>Cherrington</surname><given-names>NJ</given-names></name><name><surname>Hartley</surname><given-names>DP</given-names></name><name><surname>Buist</surname><given-names>SC</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><article-title>Tissue distribution and chemical induction of multiple drug resistance genes in rats</article-title><source>Drug Metab Dispos</source><year>2002</year><volume>30</volume><fpage>838</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">12065443</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choudhuri</surname><given-names>S</given-names></name><name><surname>Cherrington</surname><given-names>NJ</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><article-title>Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats</article-title><source>Drug Metab Dispos</source><year>2003</year><volume>31</volume><fpage>1337</fpage><lpage>1345</lpage><pub-id pub-id-type="pmid">14570765</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>VV</given-names></name><name><surname>Dahlheimer</surname><given-names>JL</given-names></name><name><surname>Bardgett</surname><given-names>ME</given-names></name><name><surname>Snyder</surname><given-names>AZ</given-names></name><name><surname>Finch</surname><given-names>RA</given-names></name><name><surname>Sartorelli</surname><given-names>AC</given-names></name><etal></etal></person-group><article-title>Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>3900</fpage><lpage>3905</lpage><pub-id pub-id-type="pmid">10097135</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AJ</given-names></name><name><surname>van Helvoort</surname><given-names>A</given-names></name><name><surname>van Meer</surname><given-names>G</given-names></name><name><surname>Szabo</surname><given-names>K</given-names></name><name><surname>Welker</surname><given-names>E</given-names></name><name><surname>Szakacs</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>23530</fpage><lpage>23539</lpage><pub-id pub-id-type="pmid">10918072</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wijnholds</surname><given-names>J</given-names></name><name><surname>deLange</surname><given-names>EC</given-names></name><name><surname>Scheffer</surname><given-names>GL</given-names></name><name><surname>Berg</surname><given-names>DJ van den</given-names></name><name><surname>Mol</surname><given-names>CA</given-names></name><name><surname>van d</surname><given-names>V</given-names></name><etal></etal></person-group><article-title>Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier</article-title><source>J Clin Invest</source><year>2000</year><volume>105</volume><fpage>279</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">10675353</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gazzin</surname><given-names>S</given-names></name><name><surname>Strazielle</surname><given-names>N</given-names></name><name><surname>Schmitt</surname><given-names>C</given-names></name><name><surname>Fevre-Montange</surname><given-names>M</given-names></name><name><surname>Ostrow</surname><given-names>JD</given-names></name><name><surname>Tiribelli</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces</article-title><source>J Comp Neurol</source><year>2008</year><volume>510</volume><fpage>497</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">18680196</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scotto</surname><given-names>KW</given-names></name></person-group><article-title>Transcriptional regulation of ABC drug transporters</article-title><source>Oncogene</source><year>2003</year><volume>22</volume><fpage>7496</fpage><lpage>7511</lpage><pub-id pub-id-type="pmid">14576854</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eloranta</surname><given-names>JJ</given-names></name><name><surname>Kullak-Ublick</surname><given-names>GA</given-names></name></person-group><article-title>Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism</article-title><source>Arch Biochem Biophys</source><year>2005</year><volume>433</volume><fpage>397</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">15581596</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kamiyama</surname><given-names>Y</given-names></name><name><surname>Matsubara</surname><given-names>T</given-names></name><name><surname>Yoshinari</surname><given-names>K</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Kamimura</surname><given-names>H</given-names></name><name><surname>Yamazoe</surname><given-names>Y</given-names></name></person-group><article-title>Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA</article-title><source>Drug Metab Pharmacokinet</source><year>2007</year><volume>22</volume><fpage>287</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">17827783</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dignam</surname><given-names>JD</given-names></name><name><surname>Lebovitz</surname><given-names>RM</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><article-title>Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei</article-title><source>Nucleic Acids Res</source><year>1983</year><volume>11</volume><fpage>1475</fpage><lpage>1489</lpage><pub-id pub-id-type="pmid">6828386</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>PK</given-names></name><name><surname>Krohn</surname><given-names>RI</given-names></name><name><surname>Hermanson</surname><given-names>GT</given-names></name><name><surname>Mallia</surname><given-names>AK</given-names></name><name><surname>Gartner</surname><given-names>FH</given-names></name><name><surname>Provenzano</surname><given-names>MD</given-names></name><etal></etal></person-group><article-title>Measurement of protein using bicinchoninic acid</article-title><source>Anal Biochem</source><year>1985</year><volume>150</volume><fpage>76</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">3843705</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kel</surname><given-names>A</given-names></name><name><surname>Reymann</surname><given-names>S</given-names></name><name><surname>Matys</surname><given-names>V</given-names></name><name><surname>Nettesheim</surname><given-names>P</given-names></name><name><surname>Wingender</surname><given-names>E</given-names></name><name><surname>Borlak</surname><given-names>J</given-names></name></person-group><article-title>A novel computational approach for the prediction of networked transcription factors of aryl hydrocarbon-receptor-regulated genes</article-title><source>Mol Pharmacol</source><year>2004</year><volume>66</volume><fpage>1557</fpage><lpage>1572</lpage><pub-id pub-id-type="pmid">15342792</pub-id></citation></ref></ref-list></back></article> 